Dysregulated stemness-related genes in gynecological malignancies

Histology and Histopathology

Volumn 27, Issue 9, 2012, Pages 1121-1130

  Mak, Victor C Y ^a   Siu, Michelle K Y ^a   Wong, Oscar G W ^a   Chan, Karen K L ^a   Ngan, Hextan Y S ^a   Cheung, Annie N Y ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Cancer stem cells; Gynecological cancers; Hedgehog; Notch; Stemness

Indexed keywords

ERINACEIDAE;

EID: 84866103351     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (76)

1. Afify A.M., Stern R. and Michael C.W. (2005). Differentiation of mesothelioma from adenocarcinoma in serous effusions: the role of hyaluronic acid and CD44 localization. Diagn. Cytopathol. 32, 145-150.
2. Akiyoshi T., Nakamura M., Koga K., Nakashima H., Yao T., Tsuneyoshi M., Tanaka M. and Katano M. (2006). Gli1, downregulated in colorectal cancers, inhibits proliferation of colon cancer cells involving Wnt signalling activation. Gut 55, 991-999.
3. Artavanis-Tsakonas S., Rand M.D. and Lake R.J. (1999). Notch signaling: cell fate control and signal integration in development. Science 284, 770-776.
4. Auersperg N., Wong A.S., Choi K.C., Kang S.K. and Leung P.C. (2001). Ovarian surface epithelium: biology, endocrinology, and pathology. Endocr. Rev. 22, 255-288.
5. Bapat S.A. (2010). Human ovarian cancer stem cells. Reproduction 140, 33-41.
6. Bapat S.A., Mali A.M., Koppikar C.B. and Kurrey N.K. (2005). Stem and progenitor-like cells contribute to the aggressive behavior of human epithelial ovarian cancer. Cancer Res. 65, 3025-3029.
7. Beachy P.A., Karhadkar S.S. and Berman D.M. (2004). Tissue repair and stem cell renewal in carcinogenesis. Nature 432, 324-331.
8. Bennett P. and Williamson C. (2010). Pathology. Basic Science in Obstetrics and Gynaecology. Fourth edn. Elsevier. p 100.
9. Bhattacharya R., Kwon J., Ali B., Wang E., Patra S., Shridhar V. and Mukherjee P. (2008). Role of hedgehog signaling in ovarian cancer. Clin. Cancer. Res. 14, 7659-7666.
10. Cantz T., Key G., Bleidissel M., Gentile L., Han D.W., Brenne A. and Scholer H.R. (2008). Absence of OCT4 expression in somatic tumor cell lines. Stem Cells 26, 692-697.
11. Chakrabarti O., Veeraraghavalu K., Tergaonkar V., Liu Y., Androphy E.J., Stanley M.A. and Krishna S. (2004). Human papillomavirus type 16 E6 amino acid 83 variants enhance E6-mediated MAPK signaling and differentially regulate tumorigenesis by notch signaling and oncogenic Ras. J. Virol. 78, 5934-5945.
12. Chambers I., Colby D., Robertson M., Nichols J., Lee S., Tweedie S. and Smith A. (2003). Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell 113, 643-655.
13. Cheung A.N. (2007). Molecular targets in gynaecological cancers. Pathology 39, 26-45.
14. Cheung A.N., Zhang H.J., Xue W.C. and Siu M.K. (2009). Pathogenesis of choriocarcinoma: clinical, genetic and stem cell perspectives. Future Oncol 5, 217-231.
15. Christian J.L. (2000). BMP, Wnt and Hedgehog signals: how far can they go? Curr. Opin. Cell Biol. 12, 244-249.
16. Clark P.A., Treisman D.M., Ebben J. and Kuo J.S. (2007). Developmental signaling pathways in brain tumor-derived stem-like cells. Dev. Dyn. 236, 3297-3308.
17. Cobellis L., Caprio F., Trabucco E., Mastrogiacomo A., Coppola G., Manente L., Colacurci N., De Falco M. and De Luca A. (2008). The pattern of expression of Notch protein members in normal and pathological endometrium. J. Anat. 213, 464-472.
18. Daniel B., Rangarajan A., Mukherjee G., Vallikad E. and Krishna S. (1997). The link between integration and expression of human papillomavirus type 16 genomes and cellular changes in the evolution of cervical intraepithelial neoplastic lesions. J. Gen. Virol. 78 (Pt 5), 1095-1101.
19. Dick J.E. (2008). Stem cell concepts renew cancer research. Blood 112, 4793-4807.
20. Evangelista M., Tian H. and de Sauvage F.J. (2006). The hedgehog signaling pathway in cancer. Clin. Cancer Res. 12, 5924-5928.
21. Friel A.M., Sergent P.A., Patnaude C., Szotek P.P., Oliva E., Scadden D.T., Seiden M.V., Foster R. and Rueda B.R. (2008). Functional analyses of the cancer stem cell-like properties of human endometrial tumor initiating cells. Cell Cycle 7, 242-249.
22. Gao Q., Geng L., Kvalheim G., Gaudernack G. and Suo Z. (2009). Identification of cancer stem-like side population cells in ovarian cancer cell line OVCAR-3. Ultrastruct. Pathol. 33, 175-181.
23. Gargett C.E. (2007). Uterine stem cells: what is the evidence? Hum. Reprod. Update 13, 87-101.
24. GLOBOCAN (2008). http://globocan.iarc.fr/
25. Harvey A.J., Armant D.R., Bavister B.D., Nichols S.M. and Brenner C.A. (2009). Inner cell mass localization of NANOG precedes OCT3/4 in rhesus monkey blastocysts. Stem Cells Dev. 18, 1451-1458.
26. Hopfer O., Zwahlen D., Fey M.F. and Aebi S. (2005). The Notch pathway in ovarian carcinomas and adenomas. Br. J. Cancer 93, 709-718.
27. Hubbard S.A., Friel A.M., Kumar B., Zhang L., Rueda B.R. and Gargett C.E. (2009). Evidence for cancer stem cells in human endometrial carcinoma. Cancer Res. 69, 8241-8248.
28. Ingham P.W. and McMahon A.P. (2001). Hedgehog signaling in animal development: paradigms and principles. Genes Dev. 15, 3059-3087.
29. Jeter C.R., Badeaux M., Choy G., Chandra D., Patrawala L., Liu C., Calhoun-Davis T., Zaehres H., Daley G.Q. and Tang D.G. (2009). Functional evidence that the self-renewal gene NANOG regulates human tumor development. Stem Cells 27, 993-1005.
30. Ji J. and Zheng P.S. (2010). Expression of Sox2 in human cervical carcinogenesis. Hum. Pathol. 41, 1438-1447.
31. Jiang L.-y., Zhang X.-l., Du P. and Zheng J.-h. (2011). G-Secretase inhibitor, DAPT inhibits self-renewal and stemness maintenance of ovarian cancer stem-like cells in vitro. Chin. J. Cancer Res. 23, 140-146.
32. Jones E.E. and Wells S.I. (2006). Cervical cancer and human papillomaviruses: inactivation of retinoblastoma and other tumor suppressor pathways. Curr. Mol. Med. 6, 795-808.
33. Kalderon D. (2002). Similarities between the Hedgehog and Wnt signaling pathways. Trends Cell Biol. 12, 523-531.
34. Kato K., Takao T., Kuboyama A., Tanaka Y., Ohgami T., Yamaguchi S., Adachi S., Yoneda T., Ueoka Y., Hayashi S., Asanoma K. and Wake N. (2010). Endometrial cancer side-population cells show prominent migration and have a potential to differentiate into the mesenchymal cell lineage. Am. J. Pathol. 176, 381-392.
35. LaBarge M.A. (2010). The difficulty of targeting cancer stem cell niches. Clin. Cancer Res. 16, 3121-3129.
36. Lapidot T., Sirard C., Vormoor J., Murdoch B., Hoang T., Caceres-Cortes J., Minden M., Paterson B., Caligiuri M.A. and Dick J.E. (1994). A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 367, 645-648.
37. Lathion S., Schaper J., Beard P. and Raj K. (2003). Notch1 can contribute to viral-induced transformation of primary human keratinocytes. Cancer Res. 63, 8687-8694.
38. Li A.S., Siu M.K., Zhang H., Wong E.S., Chan K.Y., Ngan H.Y. and Cheung A.N. (2008). Hypermethylation of SOX2 gene in hydatidiform mole and choriocarcinoma. Reprod. Sci. 15, 735-744.
39. Liao X., Siu M.K., Au C.W., Chan Q.K., Chan H.Y., Wong E.S., Ip P.P., Ngan H.Y. and Cheung A.N. (2009a). Aberrant activation of hedgehog signaling pathway contributes to endometrial carcinogenesis through beta-catenin. Mod. Pathol. 22, 839-847.
40. Liao X., Siu M.K., Au C.W., Wong E.S., Chan H.Y., Ip P.P., Ngan H.Y. and Cheung A.N. (2009b). Aberrant activation of hedgehog signaling pathway in ovarian cancers: effect on prognosis, cell invasion and differentiation. Carcinogenesis 30, 131-140.
41. Marikawa Y. and Alarcon V.B. (2009). Establishment of trophectoderm and inner cell mass lineages in the mouse embryo. Mol. Reprod. Dev. 76, 1019-1032.
42. Martens J.E., Arends J., Van der Linden P.J., De Boer B.A. and Helmerhorst T.J. (2004). Cytokeratin 17 and p63 are markers of the HPV target cell, the cervical stem cell. Anticancer Res. 24, 771-775.
43. Masui S., Nakatake Y., Toyooka Y., Shimosato D., Yagi R., Takahashi K., Okochi H., Okuda A., Matoba R., Sharov A.A., Ko M.S. and Niwa H. (2007). Pluripotency governed by Sox2 via regulation of Oct3/4 expression in mouse embryonic stem cells. Nat. Cell Biol. 9, 625-635.
44. Na J., Plews J., Li J., Wongtrakoongate P., Tuuri T., Feki A., Andrews P.W. and Unger C. (2010). Molecular mechanisms of pluripotency and reprogramming. Stem Cell Res. Ther. 1, 33.
45. Nakamura M., Kyo S., Zhang B., Zhang X., Mizumoto Y., Takakura M., Maida Y., Mori N., Hashimoto M., Ohno S. and Inoue M. (2010). Prognostic impact of CD133 expression as a tumor-initiating cell marker in endometrial cancer. Hum. Pathol. 41, 1516-1529.
46. Nichols J., Zevnik B., Anastassiadis K., Niwa H., Klewe-Nebenius D., Chambers I., Scholer H. and Smith A. (1998). Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell 95, 379-391.
47. Park J.T., Li M., Nakayama K., Mao T.L., Davidson B., Zhang Z., Kurman R.J., Eberhart C.G., Shih Ie M. and Wang T.L. (2006). Notch3 gene amplification in ovarian cancer. Cancer Res. 66, 6312-6318.
48. Parrott J.A., Kim G. and Skinner M.K. (2000). Expression and action of kit ligand/stem cell factor in normal human and bovine ovarian surface epithelium and ovarian cancer. Biol. Reprod. 62, 1600-1609.
49. Pasca di Magliano M. and Hebrok M. (2003). Hedgehog signalling in cancer formation and maintenance. Nat. Rev. Cancer 3, 903-911.
50. Peng S., Maihle N.J. and Huang Y. (2010). Pluripotency factors Lin28 and Oct4 identify a sub-population of stem cell-like cells in ovarian cancer. Oncogene 29, 2153-2159.
51. Radtke F. and Raj K. (2003). The role of Notch in tumorigenesis: oncogene or tumour suppressor? Nat. Rev. Cancer 3, 756-767.
52. Rangarajan A., Syal R., Selvarajah S., Chakrabarti O., Sarin A. and Krishna S. (2001). Activated Notch1 signaling cooperates with papillomavirus oncogenes in transformation and generates resistance to apoptosis on matrix withdrawal through PKB/Akt. Virology 286, 23-30.
53. Ray A., Meng E., Reed E., Shevde L.A. and Rocconi R.P. (2011). Hedgehog signaling pathway regulates the growth of ovarian cancer spheroid forming cells. Int. J. Oncol. 39, 797-804.
54. Sales K.M., Winslet M.C. and Seifalian A.M. (2007). Stem cells and cancer: an overview. Stem Cell Rev. 3, 249-255.
55. Schwab K.E., Hutchinson P. and Gargett C.E. (2008). Identification of surface markers for prospective isolation of human endometrial stromal colony-forming cells. Hum. Reprod. 23, 934-943.
56. Shih Ie M. (2007). Gestational trophoblastic neoplasia-pathogenesis and potential therapeutic targets. Lancet Oncol. 8, 642-650.
57. Singh S.K., Hawkins C., Clarke I.D., Squire J.A., Bayani J., Hide T., Henkelman R.M., Cusimano M.D. and Dirks P.B. (2004). Identification of human brain tumour initiating cells. Nature 432, 396-401.
58. Siu M.K., Wong E.S., Chan H.Y., Ngan H.Y., Chan K.Y. and Cheung A.N. (2008). Overexpression of NANOG in gestational trophoblastic diseases: effect on apoptosis, cell invasion, and clinical outcome. Am. J. Pathol. 173, 1165-1172.
59. Song L.L. and Miele L. (2007). Cancer stem cells--an old idea that's new again: implications for the diagnosis and treatment of breast cancer. Expert. Opin. Biol. Ther. 7, 431-438.
60. Spandidos D.A., Dokianakis D.N., Kallergi G. and Aggelakis E. (2000). Molecular basis of gynecological cancer. Ann. NY Acad. Sci. 900, 56-64.
61. Steffensen K.D., Alvero A.B., Yang Y., Waldstrom M., Hui P., Holmberg J.C., Silasi D.A., Jakobsen A., Rutherford T. and Mor G. (2011). Prevalence of epithelial ovarian cancer stem cells correlates with recurrence in early-stage ovarian cancer. J. Oncol. 2011, 620523.
62. Szotek P.P., Chang H.L., Brennand K., Fujino A., Pieretti-Vanmarcke R., Lo Celso C., Dombkowski D., Preffer F., Cohen K.S., Teixeira J. and Donahoe P.K. (2008). Normal ovarian surface epithelial labelretaining cells exhibit stem/progenitor cell characteristics. Proc. Natl. Acad. Sci. USA 105, 12469-12473.
63. Szotek P.P., Pieretti-Vanmarcke R., Masiakos P.T., Dinulescu D.M., Connolly D., Foster R., Dombkowski D., Preffer F., Maclaughlin D.T. and Donahoe P.K. (2006). Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian Inhibiting Substance responsiveness. Proc. Natl. Acad. Sci. USA 103, 11154-11159.
64. Tang D.G., Patrawala L., Calhoun T., Bhatia B., Choy G., Schneider- Broussard R. and Jeter C. (2007). Prostate cancer stem/progenitor cells: identification, characterization, and implications. Mol. Carcinog. 46, 1-14.
65. Teixeira J., Rueda B.R. and Pru J.K. (2008). Uterine stem cells. StemBook [Internet]. Harvard Stem Cell Institute. Cambridge (MA)
66. Weinmaster G. (1997). The ins and outs of notch signaling. Mol. Cell Neurosci. 9, 91-102.
67. Wong D.J., Segal E. and Chang H.Y. (2008). Stemness, cancer and cancer stem cells. Cell Cycle 7, 3622-3624.
68. Wong O.G., Huo Z., Siu M.K., Zhang H., Jiang L., Wong E.S. and Cheung A.N. (2010). Hypermethylation of SOX2 promoter in endometrial carcinogenesis. Obstet. Gynecol. Int. 2010, 682504.
69. Wu Y., Liu S., Xin H., Jiang J., Younglai E., Sun S. and Wang H. (2011). Up-regulation of microRNA-145 promotes differentiation by repressing OCT4 in human endometrial adenocarcinoma cells. Cancer 117, 3989-3998.
70. Xuan Y.H., Li G.L., Jiang H.Y. and Lin Z.H. (2009). [Relationship between hedgehog signaling pathway molecules and HPV16 infection in uterine cervical cancers]. Zhonghua Bing Li Xue Za Zhi 38, 178-182.
71. Ye F., Zhou C., Cheng Q., Shen J. and Chen H. (2008). Stem-cellabundant proteins Nanog, Nucleostemin and Musashi1 are highly expressed in malignant cervical epithelial cells. BMC Cancer 8, 108.
72. Zagouras P., Stifani S., Blaumueller C.M., Carcangiu M.L. and Artavanis-Tsakonas S. (1995). Alterations in Notch signaling in neoplastic lesions of the human cervix. Proc. Natl. Acad. Sci. USA 92, 6414-6418.
73. Zbinden M., Duquet A., Lorente-Trigos A., Ngwabyt S.N., Borges I. and Ruizi Altaba A. (2010). NANOG regulates glioma stem cells and is essential in vivo acting in a cross-functional network with GLI1 and p53. EMBO J. 29, 2659-2674.
74. Zhang H.J., Siu M.K., Wong E.S., Wong K.Y., Li A.S., Chan K.Y., Ngan H.Y. and Cheung A.N. (2008a). Oct4 is epigenetically regulated by methylation in normal placenta and gestational trophoblastic disease. Placenta 29, 549-554.
75. Zhang S., Balch C., Chan M.W., Lai H.C., Matei D., Schilder J.M., Yan P.S., Huang T.H. and Nephew K.P. (2008b). Identification and characterization of ovarian cancer-initiating cells from primary human tumors. Cancer Res. 68, 4311-4320.
76. Zhou X., Zhou Y.P., Huang G.R., Gong B.L., Yang B., Zhang D.X., Hu P. and Xu S.R. (2011). Expression of the stem cell marker, nanog, in human endometrial adenocarcinoma. Int. J. Gynecol. Pathol. 30, 262-270.